☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
amyotrophic Lateral Sclerosis (ALS)
Biogen Exercises Exclusive Worldwide Option to Develop & Commercialize Ionis's BIIB067 (IONIS-SOD1RX) for Amyotrophic Lateral...
December 7, 2018
Mitsubishi Tanabe Pharma (MTP-CA) Receives Health Canada Approval of Radicava for Amyotrophic Lateral Sclerosis (ALS)
October 5, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
